Molecular Epidemiology, Drug Susceptibility and Economic Aspects of Tuberculosis in Mubende District, Uganda

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Muwonge, Adrian ^a,g   Malama, Sydney ^a,b   Johansen, Tone B ^c   Kankya, Clovice ^d   Biffa, Demelash ^e   Ssengooba, Willy ^f   Godfroid, Jacques ^a   Djønne, Berit ^c   Skjerve, Eystein ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b Department of Health Sciences   (Zambia)

^c NORWEGIAN VETERINARY INSTITUTE   (Norway)

^d MAKERERE UNIVERSITY   (Uganda)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^f MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CROWDING; DISEASE ASSOCIATION; DRUG SENSITIVITY; ECONOMIC ASPECT; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SMOKING; TUBERCULOSIS; UGANDA; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; COINFECTION; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; UGANDA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84878608813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064745     Document Type: Article

References (43)

1. Reichman LB (2012) The global epidemic of multidrug-resistant TB, giving the sir john crofton memorial lecture on "Timebomb revisited ten years later: Can we sustain progress or are we losing the war? 43.
2. Kaufmann SHE, Schaible UE, (2005) 100th anniversary of robert koch's nobel prize for the discovery of the tubercle bacillus. Trends Microbiol 13: 469-475.
3. WHO (2012) Global tuberculosis report. WHO/HTM/TB/2012 (6) (): 9-13.
4. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, et al. (2007) Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural uganda. AIDS 21.
5. Mukadi YD, Maher D, Harries A (2001) Tuberculosis case fatality rates in high HIV prevalence populations in sub-saharan africa. AIDS 15.
6. WHO (2010) Global tuberculosis report. WHO/HTM/TB/2010 (7) (): 15-32.
7. Tupasi TE, Radhakrishna S, Quelapio MID, Villa MLA, Pascual MLG, et al. (2000) Tuberculosis in the urban poor settlements in the philippines. The International Journal of Tuberculosis and Lung Disease 4: 4-11.
8. Wen C, Chan T, Chan H, Tsai M, Cheng T, et al. (2010) The reduction of tuberculosis risks by smoking cessation. BMC Infectious Diseases 10: 156.
9. Ekrakene T, Igeleke CL, (2010) Prevalence of pulmonary tuberculosis among active and passive smokers of cigarette in benin city, nigeria. Int J Biomed& H Sci 6: 91-96.
10. Kankya C, Muwonge A, Olet S, Munyeme M, Biffa D, et al. (2010) Factors associated with pastoral community knowledge and occurrence of mycobacterial infections in human-animal interface areas of nakasongola and mubende districts, uganda. BMC Public Health 10: 471.
11. Kisa O, Tarhan G, Gunal S, Albay A, Durmaz R, et al. (2012) Distribution of spoligotyping defined genotypic lineages among drug-resistant mycobacterium tuberculosis complex clinical isolates in ankara, turkey. PLoS ONE 7: e30331.
12. Zignol M, Wayne G, Falzon D, Sismanidis C, Glaziou P, et al. (2012) Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007-2010. Bulletin WHO 90: 111-119.
13. WHO (2011) Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015. WHO Library Cataloguing-in-Publication Data WHO/HTM/TB/2011 (3) (): 7-39.
14. Bretzel G, Aziz M, Wendl-Richter U, Adatu FF, Aisu T, et al. (1999) Anti-tuberculosis drug resistance surveillance in uganda 1996-1997. The International Journal of Tuberculosis and Lung Disease 3: 810-815.
15. Rwabwogo MO (2007) Uganda district information handbook. Kampala Uganda: Fountain publishers. 10-57.
16. Wood R, Johnstone-Robertson S, Uys P, Hargrove J, Middelkoop K, et al. (2010) Tuberculosis transmission to young children in a south african community: Modeling household and community infection risks. Clin Infect Dis 51: 401-408.
17. Grimard F, Harling G (2004) The impact of tuberculosis on economic growth. McGill University, Montréal.
18. Russell S, (2004) The economic burden of illness for households in developing countries: A review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. The American Journal of Tropical Medicine and Hygiene 71: 147-155.
19. Needham DM, Godfrey-Faussett P, Foster SD, (1998) Barriers to tuberculosis control in urban zambia: The economic impact and burden on patients prior to diagnosis. The International Journal of Tuberculosis and Lung Disease 2: 811-817.
20. Brudey K, Driscoll J, Rigouts L, Prodinger W, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity: Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiology 6: 23.
21. Van Soolingen DKK, Vynycky E (2003) New perspectives in the molecular epidemiology of tuberculosis. In: Kaufmann SHE, editor. Mycobacteria and TB.: Library of congress cataloging in publication Data. 17-45.
22. Corbett EL, Bandason T, Cheung YB, Munyati S, Godfrey-Faussett P, et al. (2007) Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 4: e22.
23. Niemann S, Rüsch-Gerdes S, Joloba ML, Whalen CC, Guwatudde D, et al. (2002) Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in kampala, uganda. Journal of Clinical Microbiology 40: 3398-3405.
24. Niemann S, Kubica T, Bange FC, Adjei O, Browne EN, et al. (2004) The species mycobacterium africanum in the light of new molecular markers. Journal of Clinical Microbiology 42: 3958-3962.
25. Asiimwe BB, Koivula T, Källenius G, Huard RC, Ghebremichael S, et al. (2008) Mycobacterium tuberculosis uganda genotype is the predominant cause of TB in kampala, uganda. The International Journal of Tuberculosis and Lung Disease 12: 386-391.
26. Asiimwe B, Ghebremichael S, Kallenius G, Koivula T, Joloba M, (2008) Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban kampala, uganda. BMC Infectious Diseases 8: 101.
27. Dickman K, Nabyonga L, Kateete D, Katabazi F, Asiimwe B, et al. (2010) Detection of multiple strains of mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in kampala, uganda. BMC Infectious Diseases 10: 349.
28. Nabyonga L, Kateete D, Katabazi F, Odong P, Whalen C, et al. (2011) Determination of circulating mycobacterium tuberculosis strains and transmission patterns among pulmonary TB patients in kawempe municipality, uganda, using MIRU-VNTR. BMC Research Notes 4: 280.
29. Al-Hajoj S, Varghese B, Al-Habobe F, Shoukri MM, Mulder A, et al. (2013) Current trends of mycobacterium tuberculosis molecular epidemiology in saudi arabia and associated demographical factors. Infection, Genetics and Evolution.
30. Muwonge A, Kankya C, Olea-Popeka F, Biffa D, Sengooba W, et al. (2013) Molecular investigation of multiple strain infections in patients with tuberculosis in Mubende district, Uganda. Infect Genet Evol 13: 1348-1567.
31. Globalgiving (2010) Advocacy for 8000 TB affected persons in Mubende. Uganda health. Globalgiving co uk 2012: 1.
32. Kent PT, Kubica GP, (1985) Public health mycobacteriology: A guide for the level III laboratory. U S Dept of Health and Human Services, Public Health Service, Centers for Disease Control VIII: 207.
33. Siddiqui SH (2007) Mycobacteria growth indicator tube (MGIT) culture and drug susceptibility demonstration projects. FIND.
34. Hirano K, Aono A, Takahashi M, Abe C, (2004) Mutations including IS6110 insertion in the gene encoding the MPB64 protein of capilia TB-negative mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 42: 390-392.
35. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of mycobacterium tuberculosis for diagnosis and epidemiology. Journal of Clinical Microbiology 35: 907-914.
36. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, et al. (2006) Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of mycobacterium tuberculosis. Journal of Clinical Microbiology 44: 4498-4510.
37. Gibson A, Brown T, Baker L, Drobniewski F, (2005) Can 15-locus mycobacterial interspersed repetitive unit-variable-number tandem repeat analysis provide insight into the evolution of mycobacterium tuberculosis? Applied and Environmental Microbiology 71: 8207-8213.
38. Weniger T, Krawczyk J, Supply P, Niemann S, Harmsen D, (2010) MIRU-VNTRplus: A web tool for polyphasic genotyping of mycobacterium tuberculosis complex bacteria. Nucleic Acids Research 38: W326-W331.
39. Demay C, Liens B, Burguière T, Hill V, Couvin D, et al. (2012) SITVITWEB - A publicly available international multimarker database for studying mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infection, Genetics and Evolution 12: 755-766.
40. Hunter PR, Gaston MA, (1988) Numerical index of the discriminatory ability of typing systems: An application of simpson's index of diversity. Journal of Clinical Microbiology 26: 2465-2466.
41. Shamputa IC, Lee J, Allix-Béguec C, Cho E, Lee J, et al. (2010) Genetic diversity of mycobacterium tuberculosis isolates from a tertiary care tuberculosis hospital in south korea. Journal of Clinical Microbiology 48: 387-394.
42. Bazira J, Asiimwe B, Joloba M, Bwanga F, Matee M, (2011) Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in south-western uganda. BMC Infectious Diseases 11: 81.
43. García de Viedma D, Alonso Rodriguez N, Andrés S, Ruiz Serrano MJ, Bouza E, (2005) Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. Journal of Clinical Microbiology 43: 5660-5664.